Table 2 Biomarkers of hormone dependence and proliferative activity in breast carcinomas
Immunophenotypea | Percentage of cases (n) |
Hormone dependence | |
ERα-positive/PR-positive | 50.0 (26) |
ERα-positive/PR-negative | 11.5 (6) |
ERα-negative/PR-positive | 7.7 (4) |
ERα-negative/PR-negative | 30.8 (16) |
MIB-1 category | |
Low proliferation | 12.8 (6) |
Intermediate proliferation | 17.0 (8) |
High proliferation | 70.2 (33) |